HM1.24-aa 126-134 (HLA-A*02:01)

HM1.24-aa 126-134 (HLA-A*02:01)
€50.00 *

Prices plus VAT plus shipping costs

Delivery time 3 weeks
sterile and endotoxin free Delivery Format:
The product is supplied freeze dried as trifluoracetate salt

Amount in mg:

make your choice

  • EP07867_1
KLQDASAEV is a linear peptidic epitope (epitope ID455519) studied as part of Bone marrow stromal... more
Product information "HM1.24-aa 126-134 (HLA-A*02:01)"
KLQDASAEV is a linear peptidic epitope (epitope ID455519) studied as part of Bone marrow stromal antigen 2 from Homo sapiens (human), tested in MHC ligand assays HM1.24-aa 126-134 (HLA-A*02:01) KLQDASAEV for stimulation of T-cells. Single peptide (KLQDASAEV) for stimulation of human BST-2-specific CD8+ T-cells.KLQDASAEV is a linear peptidic epitope (epitope ID455519) studied as part of Bone marrow stromal antigen 2 from Homo sapiens (human), tested in MHC ligand assays HM1.24-aa 126-134 (HLA-A*02:01) KLQDASAEV for stimulation of T-cells. Single peptide (KLQDASAEV) for stimulation of human BST-2-specific CD8+ T-cells.KLQDASAEV is a linear peptidic epitope (epitope ID455519) studied as part of Bone marrow stromal antigen 2 from Homo sapiens (human), tested in MHC ligand assays HM1.24-aa 126-134 (HLA-A*02:01) KLQDASAEV for stimulation of T-cells. Single peptide (KLQDASAEV) for stimulation of human BST-2-specific CD8+ T-cells.

 
Sequence:KLQDASAEV
Delivery: 3 weeks
C-Terminus:OH
N-Terminus:H
Purity:95%
Amount:1 mg
Counter Ion:TFA
Species:Human
Allele:HLA-A*02:01
Application :Flow Cytometry
Indication :Cancer
Dokumente - Protokolle - Downloads more
Viewed